Volume 83, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Selecting suitable anti-malarial treatment represents one of the best tools for reducing morbidity and mortality caused by this disease. Sexual and asexual parasite dynamics were thus evaluated in patients involved in antimalarial drug efficacy studies by using combined treatment with and without artemisinin derivatives for treating uncomplicated acute malaria in Antioquia, Colombia. All treatment doses were supervised and administered according to patients' weight; sexual and asexual parasitemia were evaluated during 28- or 42-days follow-up in 468 patients. Artemisinin-based combination therapy showed greater parasiticidal ability, showing a mean asexual parasitemia survival rate of one day and mean gametocyte survival rate of 1–2 days. Sexual and asexual parasitemias were eliminated more quickly and effectively in the group receiving artemisinin-based combination therapy. Adding 45 mg of primaquine to treatment with artesunate and mefloquine reduced gametocyte and asexual parasite survival by one day.


Article metrics loading...

Loading full text...

Full text loading...



  1. WHO-UNICEF, 2005. Roll Back Malaria World Malaria Report. WHO-UNICEF, ed. Geneva: World Health Organization.
  2. WHO, 2003. Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated falciparum Malaria. Geneva: World Health Organization, WHO/CDS/CSR/RMD document. Geneva.
  3. Suh KN, Kain KC, Keystone JS, , 2004. Malaria. CMAJ 170: 16931702.
  4. Kremsner PG, Krishna S, , 2004. Antimalarial combinations. Lancet 364: 285294.[Crossref]
  5. Orjuela P, Gonzalez I, Osorio L, , 2004. Combination therapy as a strategy to prevent antimalarial drug resistance [in Spanish]. Biomedica (Bogota) 24: 423437.[Crossref]
  6. Talman AM, Domarle O, McKenzie FE, Ariey F, Robert V, , 2004. Gametocytogenesis: the puberty of Plasmodium falciparum . Malar J 3: 24.[Crossref]
  7. Arango E, Alvarez T, Carmona J, Blair S, , 2004. Gametocyte levels in response to differing malaria treatments in two municipalities of Colombia [in Spanish]. Biomedica (Bogota) 24: 7988.[Crossref]
  8. Barnes KI, White NJ, , 2005. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum . Acta Trop 94: 230240.[Crossref]
  9. Fujioka H, Aikawa M, Wahlgren M, Perlmann P, , 1999. The malaria parasite and its life-cycle. , eds. Malaria: Molecular and Clinical Aspects. Amsterdam: Harwood Academic, 2136.
  10. Price R, Nosten F, Simpson JA, Luxemburger C, Phaipun L, ter Kuile F, van Vugt M, Chongsuphajaisiddhi T, White NJ, , 1999. Risk factors for gametocyte carriage in uncomplicated falciparum malaria. Am J Trop Med Hyg 60: 10191023.
  11. Carmona-Fonseca J, , 2004. La malaria en Colombia, Antioquia y las zonas de Urabá y Bajo Cauca: panorama para interpretar la falla terapéutica antimalárica. Parte 2. Iatreia 17: 3453.
  12. Dirección Seccional de Salud de Antioquia, Eventos en Salud Pública. Serie Infeccosas, 1998–2007. Available at: http://www.dssa.gov.co/index.php/estadisticas/eventos-de-salud-publica. Accessed February 26, 2010.
  13. Montoya L, Maestre A, Carmona J, Lopes D, Do Rosario V, Blair S, , 2003. Plasmodium falciparum: diversity studies of isolates from two Colombian regions with different endemicity. Exp Parasitol 104: 1419.[Crossref]
  14. Montoya P, Tobón A, Blair S, Carmona J, Maestre A, , 2007. Polymorphisms of the pfmdr1 gene in field samples of Plasmodium falciparum and their association with therapeutic response to antimalarial drugs and severe malaria in Colombia. Biomedica (Bogota) 27: 204215.[Crossref]
  15. Restrepo E, Carmona-Fonseca J, Maestre A, , 2008. Plasmodium falciparum: high frequency of pfcrt point mutations and emergence of new mutant haplotypes in Colombia. Biomedica (Bogota) 28: 523530.
  16. López-Antuñano FJ, López-Antuñano FJ, , 1988. Diagnostico microscópico de los parásitos de la malaria en la sangre. , ed. Diagnosis de Malaria. Washington: Pan-American Health Organization, 3950.
  17. von Seidlein L, Jawara M, Coleman R, Doherty T, Walraven G, Targett G, , 2001. Parasitemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria. Trop Med Int Health 6: 9298.[Crossref]
  18. Bousema JT, Gouagna LC, Drakeley CJ, Meutstege AM, Okech BA, Akim IN, Beier JC, Githure JI, Sauerwein RW, , 2004. l. Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Malar J 3: 18.[Crossref]
  19. El-Sayed B, El-Zaki SE, Babiker H, Gadalla N, Ageep T, Mansour F, Baraka O, Milligan P, Babiker A, , 2007. A randomized open-label trial of artesunate-sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in eastern Sudan. PLoS One 2: e1311.[Crossref]
  20. Carmona-Fonseca J, Alvarez G, Maestre A, , 2009. Methemoglobinemia and adverse events in Plasmodium vivax malaria patients associated with high doses of primaquine treatment. Am J Trop Med Hyg 80: 188193.
  21. Carmona-Fonseca J, Alvarez G, Rios A, Vasquez MF, , 2008. Deficiencia de glucosa 6-fostato deshidrogenasa en hombres sanos y en pacientes maláricos; Turbo (Antioquia, Colombia). Rev Bras Epidemiol 11: 252265.[Crossref]
  22. Baird JK, Hoffman SL, , 2004. Primaquine therapy for malaria. Clin Infect Dis 39: 13361345.[Crossref]
  23. Von Seidlein L, Drakeley C, Greenwood B, Walraven G, Targett G, , 2001. Risk factors for gametocyte carriage in Gambian children. Am J Trop Med Hyg 65: 523527.
  24. Beutler E, , 1997. Glucose-6-phospate dehydrogenase deficiency: diagnosis, clinical and genetic implications. Am J Clin Pathol 47: 303311.[Crossref]
  25. Stepniewska K, Price RN, Sutherland CJ, Drakeley CJ, von Seidlein L, Nosten F, White NJ, , 2008. Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity. Malar J 7: 249.[Crossref]

Data & Media loading...

  • Received : 26 May 2009
  • Accepted : 06 Apr 2010

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error